ICAM1 and lung carcinoma: Ropivacaine treatment was shown to have beneficial antimetastatic effects on NCI-H838 lung cancer cells, potentially by suppressing tumor necrosis factor-α-induced src-activation and intercellular adhesion molecule-1 phosphorylation (Piegeler et al., 2012).